An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.

RecruitingOBSERVATIONAL
Enrollment

308

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)Primary Liver Cancer
Interventions
DIAGNOSTIC_TEST

Multi-modal ultrasonic imaging system for liver cancer

Conventional ultrasound, SMI, shear wave /strain elastography, and CEUS will be conducted for HCC/ICC patients. All above the imaging examinations will be conducted at 1/2/3/4/5/6, 9/12/15/18/21/24, and 30/36/42/48/54/60 months after the postoperative/post-conversion therapy.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER